Detalhe da pesquisa
1.
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Blood
; 143(6): 496-506, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879047
2.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614146
3.
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Am J Hematol
; 99(3): 408-421, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217361
4.
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031804
5.
Personalised therapy in follicular lymphoma - is the dial turning?
Hematol Oncol
; 2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482955
6.
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(1): 91-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895487
7.
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
Blood
; 135(26): 2365-2374, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32211877
8.
How do you define treatment success in MZL?
Blood
; 143(5): 382-383, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300612
9.
How I treat early-relapsing follicular lymphoma.
Blood
; 133(14): 1540-1547, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700421
10.
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Blood
; 133(18): 1964-1976, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850381
11.
Upfront identification of high-risk follicular lymphoma.
Hematol Oncol
; 39 Suppl 1: 88-93, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105811
12.
Early Progressing Follicular Lymphoma.
Curr Oncol Rep
; 23(12): 149, 2021 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797453
13.
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Am J Hematol
; 95(12): 1503-1510, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32815559
14.
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Acta Haematol
; 143(1): 40-50, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31315113
15.
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Cancer
; 125(9): 1507-1517, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694529
16.
How I manage patients with follicular lymphoma.
Br J Haematol
; 186(4): 513-523, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173345
17.
Author gender representation of journal reviews and editorials on lymphoma (2017-22).
Lancet
; 402(10401): 523-525, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573074
18.
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 24(6): 1163-1171, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242111
19.
Checkpoint blockade in FL: eluding the king.
Blood
; 137(5): 581-582, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538800
20.
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.
Blood
; 128(11): 1458-64, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458003